CIK 0001711279
- Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 821080209
- Phone
- +1 412-586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Shares withheld for taxes President, R&D gave up 9,256 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 9,256 shares (to pay taxes)
- 4 Shares withheld for taxes President, R&D gave up 2,353 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,791 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 8,087 shares at an average $136.91 ($1,107,180)
- 4 Planned sale Chief Accounting Officer sold 2,500 shares at $130.00 ($325,000)
- 4 Planned sale President, R&D sold 50,000 shares at an average $105.67 ($5,283,291)
- 4 Planned sale President and CEO sold 50,000 shares at an average $105.67 ($5,283,291)
- 4 Planned sale President, R&D sold 50,000 shares at an average $127.23 ($6,361,680)
- 4 Planned sale President and CEO sold 50,000 shares at an average $127.23 ($6,361,680)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 50,000 shares at an average $128.36 ($6,418,077)
- 4 Planned sale Chief Commercial Officer sold 12,500 shares at an average $128.61 ($1,607,635)
- 4 Open-market sale President, R&D sold 50,000 shares at an average $116.20 ($5,809,889)
- 4 Open-market sale President and CEO sold 50,000 shares at an average $116.20 ($5,809,889)
Page 4 of 10 · 186 filings